˿Ƶ


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended January 31, 2015

  

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission file number: 000-55107

 

˿Ƶ.

(Exact name of registrant as specified in its charter)

 

Delaware

27-1933597

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

720 South Colorado Boulevard, Suite 1150N

Denver, CO

 

80246

(Address of principal executive offices)

(Zip Code)

 

Registrants telephone number: (303) 333-4224

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days Yes þ  No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

o

Accelerated filer

o

Non-accelerated filer 

o (Do not check if a smaller reporting company)

Smaller reporting company

þ

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o  No þ

 

Class

 

Outstanding as of March 10, 2015

Common Stock, $0.001 par value per share

 

113,098,156 shares

 

 




INDEX


 

PART I – FINANCIAL INFORMATION

 

                      

 

 

Item 1.

Financial Statements.

1

 

 

 

 

Consolidated Balance Sheets

1

 

 

 

 

Consolidated Statements of Operations (Unaudited)

3

 

 

 

 

Consolidated Statements of Changes in Stockholders Equity (Deficiency) (Unaudited)

4

 

 

 

 

Consolidated Statements of Cash Flows (Unaudited)

5

 

 

 

 

Condensed Notes to Consolidated Financial Statements (Unaudited)

7

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

22

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

32

 

 

 

Item 4.

Controls and Procedures.

32

 

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings.

33

 

 

 

Item 1A.

Risk Factors.

33

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

33

 

 

 

Item 3.

Defaults Upon Senior Securities.

34

 

 

 

Item 4.

Mine Safety Disclosures.

34

 

 

 

Item 5.

Other Information.

34

 

 

 

Item 6.

Exhibits.

34


SIGNATURES

35








PART I. FINANCIAL INFORMATION


ITEM 1. FINANCIAL STATEMENTS


ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


 

 

January 31,

 

 

April 30,

 

 

 

2015

 

 

2014

 

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,158,339

 

 

$

247,380

 

Restricted cash

 

 

888,225

 

 

 

868,298

 

Accounts receivable, net of allowance of $241,027 and $221,537, respectively

 

 

888,499

 

 

 

649,890

 

Prepaid expenses

 

 

66,019

 

 

 

45,884

 

Net assets from discontinued operations (Note 1)

 

 

 

 

 

5,250

 

Total current assets

 

 

3,001,082

 

 

 

1,816,702

 

 

 

 

 

 

 

 

 

 

Property and equipment:

 

 

 

 

 

 

 

 

Call center equipment

 

 

132,798

 

 

 

122,653

 

Computer and office equipment

 

 

73,286

 

 

 

66,118

 

Furniture and fixtures

 

 

42,698

 

 

 

36,446

 

Library (online)

 

 

100,000

 

 

 

100,000

 

Software

 

 

2,147,783

 

 

 

1,894,215

 

 

 

 

2,496,565

 

 

 

2,219,432

 

Less accumulated depreciation and amortization

 

 

(1,268,502

)

 

 

(938,703

)

Total property and equipment, net

 

 

1,228,063

 

 

 

1,280,729

 

Courseware, net

 

 

158,280

 

 

 

108,882

 

Accounts receivable, secured - related party, net of allowance of $625,962, and $625,962, respectively

 

 

146,831

 

 

 

146,831

 

Debt issuance costs, net

 

 

 

 

 

205,515

 

Other assets

 

 

26,678

 

 

 

25,181

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

4,560,934

 

 

$

3,583,840

 


(Continued)





1





ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)


 

 

January 31,

 

 

April 30,

 

 

 

2015

 

 

2014

 

 

 

(Unaudited)

 

 

 

 

Liabilities and Stockholders' Equity (Deficiency)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

458,997

 

 

$

454,783

 

Accrued expenses

 

 

223,072

 

 

 

144,466

 

Deferred revenue

 

 

716,642

 

 

 

653,518

 

Refunds Due Students

 

 

373,161

 

 

 

288,121

 

Deferred rent, current portion

 

 

11,750

 

 

 

13,699

 

Convertible notes payable, current portion

 

 

50,000

 

 

 

175,000

 

Debenture payable, net of discounts of $0 and $452,771

 

 

 

 

 

1,787,229

 

Total current liabilities

 

 

1,833,622

 

 

 

3,516,816

 

 

 

 

 

 

 

 

 

 

Line of credit

 

 

243,989

 

 

 

244,175

 

Loan payable officer - related party

 

 

1,000,000

 

 

 

1,000,000

 

Convertible notes payable - related party

 

 

600,000

 

 

 

600,000

 

Deferred rent

 

 

 

 

 

7,751

 

Total liabilities

 

 

3,677,611

 

 

 

5,368,742

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies - See Note 8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity (deficiency):

 

 

 

 

 

 

 

 

Common stock, $0.001 par value; 250,000,000 shares authorized, 113,298,156 issued and 113,098,156 outstanding at January 31, 2015, 73,414,478 issued and 73,214,478 outstanding at April 30, 2014

 

 

113,298

 

 

 

73,414

 

Additional paid-in capital

 

 

22,170,190

 

 

 

16,302,118

 

Treasury stock (200,000 shares)

 

 

(70,000

)

 

 

(70,000

)

Accumulated deficit

 

 

(21,330,165

)

 

 

(18,090,434

)

Total stockholders' equity (deficiency)

 

 

883,323

 

 

 

(1,784,902

)

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity (deficiency)

 

$

4,560,934

 

 

$

3,583,840

 



The accompanying unaudited notes are an integral part of these unaudited consolidated financial statements.




2





ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


 

 

For the

 

 

For the

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

January 31,

 

 

January 31,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

1,286,138

 

 

$

1,002,167

 

 

$

3,670,245

 

 

$

2,817,497

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues (exclusive of depreciation and amortization shown separately below)

 

 

662,368

 

 

 

500,311

 

 

 

1,524,793

 

 

 

1,390,444

 

General and administrative

 

 

1,701,871

 

 

 

1,752,717

 

 

 

4,160,978

 

 

 

4,866,498

 

Receivable collateral valuation reserve

 

 

 

 

 

123,647

 

 

 

 

 

 

123,647

 

Depreciation and amortization

 

 

133,966

 

 

 

121,904

 

 

 

389,706

 

 

 

350,990

 

Total operating expenses

 

 

2,498,205

 

 

 

2,498,579

 

 

 

6,075,477

 

 

 

6,731,579

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating loss from continuing operations

 

 

(1,212,067

)

 

 

(1,496,412

)

 

 

(2,405,232

)

 

 

(3,914,082

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

2,277

 

 

 

136

 

 

 

7,157

 

 

 

750

 

Loss on Debt Extinguishment

 

 

 

 

 

 

 

 

(452,503

)

 

 

 

Interest expense

 

 

(34,532

)

 

 

(260,062

)

 

 

(389,153

)

 

 

(398,916

)

Total other expense, net

 

 

(32,255

)

 

 

(259,926

)

 

 

(834,499

)

 

 

(398,166

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from continuing operations before income taxes

 

 

(1,244,322

)

 

 

(1,756,338

)

 

 

(3,239,731

)

 

 

(4,312,248

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from continuing operations

 

 

(1,244,322

)

 

 

(1,756,338

)

 

 

(3,239,731

)

 

 

(4,312,248

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations (Note 1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations, net of income taxes

 

 

 

 

 

29,751

 

 

 

 

 

 

84,663

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(1,244,322

)

 

$

(1,726,587

)

 

$

(3,239,731

)

 

$

(4,227,585

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share from continuing operations - basic and diluted

 

$

(0.01

)

 

$

(0.03

)

 

$

(0.03

)

 

$

(0.07

)

Income per share from discontinued operations - basic and diluted

 

$

 

 

$

0.00

 

 

$

 

 

$

0.00

 

Net loss per share allocable to common stockholders - basic and diluted

 

$

(0.01

)

 

$

(0.03

)

 

$

(0.03

)

 

$

(0.07

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

basic and diluted

 

 

112,753,454

 

 

 

59,780,884

 

 

 

96,548,329

 

 

 

59,098,885

 



The accompanying unaudited notes are an integral part of these unaudited consolidated financial statements.




3





ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIENCY)

FOR THE NINE MONTHS ENDED January 31, 2015

(Unaudited)


 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

Stockholders'

 

 

 

Common Stock

 

 

Paid-In

 

 

Treasury

 

 

Accumulated

 

 

Equity

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

(Deficiency)

 

Balance at April 30, 2014

 

 

73,414,478

 

 

$

73,414

 

 

$

16,302,118

 

 

$

(70,000

)

 

$

(18,090,434

)

 

$

(1,784,902

)

Issuance of common shares for cash

 

 

35,614,154

 

 

 

35,615

 

 

 

5,512,211

 

 

 

 

 

 

 

 

 

5,547,826

 

Offering cost for professional services from private placement

 

 

 

 

 

 

 

 

(107,225

)

 

 

 

 

 

 

 

 

(107,225

)

Stock-based compensation

 

 

 

 

 

 

 

 

334,723

 

 

 

 

 

 

 

 

 

334,723

 

Shares issued for price protection

 

 

3,532,682

 

 

 

3,532

 

 

 

(3,532

)

 

 

 

 

 

 

 

 

 

Conversion of convertible debt into shares

 

 

526,316

 

 

 

526

 

 

 

99,474

 

 

 

 

 

 

 

 

 

100,000

 

Shares issued for services rendered

 

 

210,526

 

 

 

211

 

 

 

32,421

 

 

 

 

 

 

 

 

 

32,632

 

Net loss, nine months ended January 31, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,239,731

)

 

 

(3,239,731

)

Balance at January 31, 2015

 

 

113,298,156

 

 

$

113,298

 

 

$

22,170,190

 

 

$

(70,000

)

 

$

(21,330,165

)

 

$

883,323

 



The accompanying unaudited notes are an integral part of these unaudited consolidated financial statements.






4





ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


 

 

For the

 

 

 

Nine Months Ended

January 31,

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(3,239,731

)

 

$

(4,227,585

)

Less income from discontinued operations

 

 

 

 

 

84,663

 

Loss from continuing operations

 

 

(3,239,731

)

 

 

(4,312,248

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Bad debt expense

 

 

117,739

 

 

 

148,837

 

Receivable collateral valuation reserve

 

 

 

 

 

123,647

 

Amortization of debt issuance costs

 

 

75,458

 

 

 

77,058

 

Amortization of debt discount

 

 

166,241

 

 

 

174,351

 

Extinguishment of debentures

 

 

416,587

 

 

 

 

Depreciation and amortization

 

 

389,706

 

 

 

350,990

 

Stock-based compensation

 

 

334,723

 

 

 

395,940

 

Warrant modification expense

 

 

 

 

 

156,952

 

Amortization of prepaid shares for services

 

 

 

 

 

285,084

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(356,348

)

 

 

(443,863

)

Prepaid expenses

 

 

(20,135

)

 

 

58,922

 

Other assets

 

 

(1,497

)

 

 

 

Accounts payable

 

 

4,214

 

 

 

63,195

 

Accrued expenses

 

 

111,238

 

 

 

4,578

 

Deferred rent

 

 

(9,700

)

 

 

(7,239

)

Refunds due students

 

 

85,040

 

 

 

(18,572

)

Deferred revenue

 

 

63,124

 

 

 

(98,430

)

Net cash used in operating activities

 

 

(1,863,341

)

 

 

(3,040,798

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(277,133

)

 

 

(298,140

)

Purchases of courseware

 

 

(109,305

)

 

 

(4,499

)

Increase in restricted cash

 

 

(19,927

)

 

 

(406

)

Net cash used in investing activities

 

 

(406,365

)

 

 

(303,045

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from (repayments on) line of credit, net

 

 

(186

)

 

 

(5,825

)

Proceeds from issuance of common shares and warrants, net

 

 

5,547,826

 

 

 

 

Proceeds from (retirement of) convertible notes and warrants, net of costs

 

 

(2,240,000

)

 

 

1,639,298

 

Retirement of convertible notes payable

 

 

(25,000

)

 

 

 

Proceeds from loan from related party

 

 

 

 

 

1,000,000

 

Proceeds from warrant exercise

 

 

 

 

 

804,049

 

Offering costs associated with private placement

 

 

(107,225

)

 

 

(48,240

)

Net cash provided by financing activities

 

 

3,175,415

 

 

 

3,389,282

 

 

 

 

 

 

 

 

 

 

Cash flows from discontinued operations:

 

 

 

 

 

 

 

 

Cash flows from operating activities

 

 

5,250

 

 

 

80,206

 

Net cash provided by discontinued operations

 

 

5,250

 

 

 

80,206

 

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

910,959

 

 

 

125,645

 

Cash and cash equivalents at beginning of period

 

 

247,380

 

 

 

724,982

 

Cash and cash equivalents at end of period

 

$

1,158,339

 

 

$

850,627

 


(Continued)



5





ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(Unaudited)


 

 

For the

 

 

 

Nine Months Ended

January 31,

 

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

212,955

 

 

$

95,653

 

Cash paid for income taxes

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing activities

 

 

 

 

 

 

 

 

Common stock issued for services

 

$

32,632

 

 

$

216,000

 

Common stock issued from conversion of notes

 

$

100,000

 

 

$

 

Warrant value recorded as debt issue cost

 

$

 

 

$

94,316

 

Warrant value recorded as debt discount

 

$

 

 

$

389,565

 



The accompanying unaudited notes are an integral part of these unaudited consolidated financial statements.





6





ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

January 31, 2015

(Unaudited)


Note 1. Nature of Operations and Liquidity


Overview


˿Ƶ. (together with its subsidiary, the “Company” or “Aspen”) is a holding company. Its subsidiary Aspen University Inc. was founded in Colorado in 1987 as the International School of Information Management. On September 30, 2004, it changed its name to Aspen University Inc. (“Aspen University”).  On March 13, 2012, the Company was recapitalized in a reverse merger. All references to the Company or Aspen before March 13, 2012 are to Aspen University.


On April 5, 2013, the Company gave 120-day notice to CLS 123, LLC of its intent to terminate the agreement between the Company and CLS 123, LLC dated November 9, 2011. Moreover, at the end of the 120-day period, the Company no longer offered the “Certificate in Information Technology with a specialization in Smart Home Integration” program. Accordingly, the activities related to CLS (or the “Smart Home Integration Certificate” program) are treated as discontinued operations. As this component of the business was not sold, there was no gain or loss on the disposition of this component (see below “Discontinued Operations”).


On April 25, 2013, our Board of Directors approved a change in our fiscal year-end from December 31 to April 30, with the change to the calendar year reporting cycle beginning May 1, 2013. Consequently, we filed a Transition Report on Form 10-KT for the four-month transition period ended April 30, 2013.


Aspen University’s mission is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education for the purpose of achieving sustainable economic and social benefits for themselves and their families. One of the key differences between Aspen and other publicly-traded, exclusively online, for-profit universities is that approximately 38% of our full-time degree-seeking students (as of January 31, 2015) were enrolled in Aspen’s School of Nursing.


On November 10, 2014, Aspen University announced the Commission on Collegiate Nursing Education (“CCNE”) has granted accreditation to its Bachelor of Science in Nursing program (RN to BSN) until December 31, 2019. This newly accredited undergraduate degree program is expected to grow rapidly given Aspen’s debtless education approach, which allows nurses to pay the $9,750 tuition for the 10-course RN to BSN completion program at $250 per month for 39 months. In fact, Aspen projects the BSN program to be the largest growth driver in the next 12 months, which we estimate will result in over 50% or the majority of the degree-seeking student body to be enrolled in the School of Nursing by early-2016. Initial marketing and enrollment results support this forecast.


Since 1993, we have been nationally accredited by the Distance Education and Accrediting Council (“DEAC”), a national accrediting agency recognized by the U.S. Department of Education (the “DOE”).  On February 25, 2015, the DEAC informed Aspen University that it had renewed its accreditation for five years to January, 2019.


Basis of Presentation


A. Interim Financial Statements


The interim consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three months ended January 31, 2015 and 2014, the nine months ended January 31, 2015 and 2014, our cash flows for the nine months ended January 31, 2015 and 2014, and our financial position as of January 31, 2015 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.


Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim consolidated financial statements. Accordingly, these interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Report on Form 10-K for the period ended April 30, 2014 as filed with the SEC on July 29, 2014. The April 30, 2014 balance sheet is derived from those statements.



7



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



B. Discontinued Operations


As of March 31, 2013, the Company decided to discontinue business activities related to its “Certificate in Information Technology with a specialization in Smart Home Integration” program so that it may focus on growing its full-time, degree-seeking student programs, which have higher gross margins. On April 5, 2013, the Company gave 120-day notice to CLS 123, LLC of its intent to terminate the agreement between the Company and CLS 123, LLC dated November 9, 2011. Thus, as of August 3, 2013, the Company is no longer offering the “Certificate in Information Technology with a specialization in Smart Home Integration” program. The termination of the “Smart Home Integration Certificate” program qualifies as a discontinued operation and accordingly the Company has excluded results for this component from its continuing operations in the consolidated statements of operations for all periods presented. The following table shows the results of the “Smart Home Integration Certificate” program component included in the income (loss) from discontinued operations:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

January 31,

 

 

Nine Months Ended

January 31,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

 

 

$

 

 

$

 

 

$

549,125

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instructional costs and services

 

 

 

 

 

 

 

 

 

 

 

494,213

 

General and administrative

 

 

 

 

 

(29,751

)

 

 

 

 

 

(29,751

)

Total costs and expenses

 

 

 

 

 

(29,751

)

 

 

 

 

 

464,462

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from discontinued operations, net of income taxes

 

$

 

 

$

29,751

 

 

$

 

 

$

84,663

 

 

The major classes of assets and liabilities of discontinued operations on the balance sheet are as follows:

  

 

 

January 31,

 

 

April 30,

 

 

 

2015

 

 

2014

 

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

 

$

 

Accounts receivable, net of allowance of $486,781, and $481,531, respectively

 

 

 

 

 

5,250

 

Other current assets

 

 

 

 

 

 

Net assets from discontinued operations

 

$

 

 

$

5,250

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

 

 

$

 

Accrued expenses

 

 

 

 

 

 

Deferred revenue

 

 

 

 

 

 

Net liabilities from discontinued operations

 

$

 

 

$

 


C. Liquidity


At January 31, 2015, the Company had a cash balance of approximately $2.0 million which includes $888,225 of restricted cash. In September 2014, the Company completed the second closing of its equity financing of $3,766,325. With the additional cash raised in the financing, the growth in the Company revenues and improving operating margins, the Company believes that it has sufficient cash to allow the Company to implement its long-term business plan.




8



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



Note 2. Significant Accounting Policies


Principles of Consolidation


The unaudited consolidated financial statements include the accounts of ˿Ƶ. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.


Use of Estimates


The preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts in the unaudited consolidated financial statements. Actual results could differ from those estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the allowance for doubtful accounts and other receivables, the valuation of collateral on certain receivables, amortization periods and valuation of courseware and software development costs, valuation of beneficial conversion features in convertible debt, valuation of stock-based compensation, the valuation of net assets and liabilities from discontinued operations and the valuation allowance on deferred tax assets.


Cash and Cash Equivalents


For the purposes of the unaudited condensed consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at January 31, 2015 and April 30, 2014 respectively. The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits of $250,000 per financial institution. The Company has not experienced any losses in such accounts from inception through January 31, 2015. As of January 31, 2015, there was $176,602, $760,169 and $638,028 located in three institutions greater than the federally insured limits.


Restricted Cash


Restricted cash represents amounts pledged as security for letters of credit for transactions involving Title IV programs, as well as funds held in escrow. The company considers $888,225 and $868,298 as restricted cash (shown as a current asset as of January 31, 2015 and April 30, 2014 respectively).


Fair Value Measurements


Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The Company classifies assets and liabilities recorded at fair value under the fair value hierarchy based upon the observability of inputs used in valuation techniques. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. The fair value measurements are classified under the following hierarchy:


Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;

Level 2—Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and

Level 3—Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.


The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.



9



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



Refunds Due Students


The Company receives Title IV funds from the Department of Education to cover tuition and living expenses. Until forwarded to the student, this amount is captured in a current liability account called Refunds Due Students. Typically, the funds are paid to the students within two weeks.


Revenue Recognition and Deferred Revenue


Revenues consist primarily of tuition and fees derived from courses taught by the Company online as well as from related educational resources that the Company provides to its students, such as access to our online materials and learning management system. Tuition revenue is recognized pro-rata over the applicable period of instruction. The Company allows a student to make three monthly tuition payments during each 10-week class. The Company maintains an institutional tuition refund policy, which provides for all or a portion of tuition to be refunded if a student withdraws during stated refund periods. Certain states in which students reside impose separate, mandatory refund policies, which override the Company’s policy to the extent in conflict. If a student withdraws at a time when a portion or none of the tuition is refundable, then in accordance with its revenue recognition policy, the Company recognizes as revenue the tuition that was not refunded. Since the Company recognizes revenue pro-rata over the term of the course and because, under its institutional refund policy, the amount subject to refund is never greater than the amount of the revenue that has been deferred, under the Company’s accounting policies revenue is not recognized with respect to amounts that could potentially be refunded. The Company’s educational programs have starting and ending dates that differ from its fiscal quarters. Therefore, at the end of each fiscal quarter, a portion of revenue from these programs is not yet earned and is therefore deferred. The Company also charges students annual fees for library, technology and other services, which are recognized over the related service period. Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets. Other revenues may be recognized as sales occur or services are performed.


Net Loss Per Share


Net loss per common share is based on the weighted average number of common shares outstanding during each period. Options to purchase 14,576,412 and 9,583,086 common shares, warrants to purchase 44,007,963 and 19,196,635 common shares, and $650,000 and $2,240,000 of convertible debt (convertible into 1,207,143 and 8,093,985 common shares, respectively) were outstanding during the nine months ended January 31, 2015 and 2014, respectively, but were not included in the computation of diluted loss per share because the effects would have been anti-dilutive. The options, warrants and convertible debt are considered to be common stock equivalents and are only included in the calculation of diluted earnings per common share when their effect is dilutive.


Reclassifications


For the three and the nine months ending January 31, 2014, the Company reclassified $55,314 and $168,155 respectively, from Cost of Revenues to General and Administrative, both within Operating Expenses, to conform to the current period presentation.


 

 

For the 9 Months ended January 31, 2014

 

 

 

Reclassifications

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dues,

 

 

Internet

 

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

Fees, &

 

 

Related

 

 

Marketing

 

 

Library

 

 

As

 

 

 

Reported

 

 

Licenses

 

 

Expense

 

 

Fees

 

 

Services

 

 

Reclassified

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instructional

 

$

734,597

 

 

 

(55,127

)

 

 

(113,028

)

 

 

 

 

 

$

566,442

 

Marketing

 

 

824,002

 

 

 

 

 

 

 

 

 

 

 

 

 

824,002

 

Cost of Revenues

 

$

1,558,599

 

 

 

(55,127

)

 

 

(113,028

)

 

 

 

 

 

 

 

$

1,390,444

 

Receivable collateral valuation reserve

 

 

123,647

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

123,647

 

General and administrative

 

 

4,698,343

 

 

 

55,127

 

 

 

113,028

 

 

 

 

 

 

 

 

 

4,866,498

 

Depreciation and amortization

 

 

350,990

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

350,990

 

Total Operating Expenses

 

$

6,731,579

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

6,731,579

 



10



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)




 

 

For the 3 Months ended January 31, 2014

 

 

 

Reclassifications

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dues,

 

 

Internet

 

 

 

 

 

 

 

 

 

 

 

 

As Previously

 

 

Fees, &

 

 

Related

 

 

Marketing

 

 

Library

 

 

As

 

 

 

Reported

 

 

Licenses

 

 

Expense

 

 

Fees

 

 

Services

 

 

Reclassified

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instructional

 

$

285,221

 

 

 

(14,878

)

 

 

(40,436

)

 

 

 

 

 

$

229,907

 

Marketing

 

 

270,404

 

 

 

 

 

 

 

 

 

 

 

 

 

270,404

 

Cost of Revenues

 

$

555,625

 

 

 

(14,878

)

 

 

(40,436

)

 

 

 

 

 

 

 

$

500,311

 

Receivable collateral valuation reserve

 

 

123,647

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

123,647

 

General and administrative

 

 

1,697,403

 

 

 

14,878

 

 

 

40,436

 

 

 

 

 

 

 

 

 

1,752,717

 

Depreciation and amortization

 

 

121,904

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

121,904

 

Total Operating Expenses

 

$

2,498,579

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2,498,579

 


Recent Accounting Pronouncements


Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after January 31, 2015 are not expected to have a significant effect on the Company’s unaudited consolidated financial position or results of operations.


In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company does not expect the implementation of this standard to have a material effect on it disclosures.


Note 3. Secured Note and Accounts Receivable – Related Parties


On March 30, 2008 and December 1, 2008, the Company sold courseware pursuant to marketing agreements to Higher Education Management Group, Inc. (“HEMG”,) which was then a related party and principal stockholder of the Company. HEMG’s president is Mr. Patrick Spada, the former Chairman of the Company, in the amount of $455,000 and $600,000, respectively; UCC filings were filed accordingly. Under the marketing agreements, the receivables were due net 60 months. On September 16, 2011, HEMG pledged 772,793 Series C preferred shares (automatically converted to 654,850 common shares on March 13, 2012) of the Company as collateral for this account receivable. On March 8, 2012, due to the impending reduction in the value of the collateral as the result of the Series C conversion ratio and the Company’s inability to engage Mr. Spada in good faith negotiations to increase HEMG’s pledge, Michael Mathews, the Company’s CEO, pledged 117,943 common shares of the Company, owned personally by him, valued at $1.00 per share based on recent sales of capital stock as additional collateral to the accounts receivable, secured – related party. On March 13, 2012, the Company deemed the receivables stemming from the sale of courseware curricula to be in default. On April 4, 2012, the Company entered into an agreement with: (i) an individual, (ii) HEMG, and (iii) Mr. Patrick Spada. Under the agreement, (a) the individual purchased and HEMG sold to the individual 400,000 common shares of the Company at $0.50 per share; (b) the Company guaranteed it would purchase at least 600,000 common shares of the Company at $0.50 per share within 90 days of the agreement and the Company would use its best efforts to purchase from HEMG and resell to investors an additional 1,400,000 common shares of the Company at $0.50 per share within 180 days of the agreement; and (c) the Company waived any default of the accounts receivable, secured - related party and extended the due date to September 30, 2014. Based on proceeds received on September 28, 2012 under a private placement at $0.35 per unit (consisting of one share of common stock and one-half of a warrant exercisable at $0.50 per share), the value of the aforementioned collateral decreased. Accordingly, as of December 31, 2012, the Company recognized an allowance of $502,315 for this account receivable. Based on the reduction in value of the collateral to $0.19, the Company recognized an expense of $123,647 during the year ended April 30, 2014 as an additional allowance. As of both April 30, 2014, and January 31, 2015, the balance of the account receivable, net of allowance, was $146,831.



11



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



HEMG has failed to pay to Aspen University any portion of the $772,793 amount due as of September 30, 2014, despite due demand for same. Consequently, on November 18, 2014 Aspen University filed a complaint vs. HEMG in the United States District Court for the District of New Jersey, to collect the full amount due to the Company. HEMG defaulted. In addition, Aspen University gave notice to HEMG that it intended to privately sell the 654,850 shares after March 10, 2015. (See Note 11)


Note 4. Property and Equipment


Property and equipment consisted of the following at January 31, 2015 and April 30, 2014:


 

 

January 31,

 

 

April 30,

 

 

 

2015

 

 

2014

 

Call center hardware

 

$

132,798

 

 

$

122,653

 

Computer and office equipment

 

 

73,286

 

 

 

66,118

 

Furniture and fixtures

 

 

42,698

 

 

 

36,446

 

Library (online)

 

 

100,000

 

 

 

100,000

 

Software

 

 

2,147,783

 

 

 

1,894,215

 

 

 

 

2,496,565

 

 

 

2,219,432

 

Accumulated depreciation and amortization

 

 

(1,268,502

)

 

 

(938,703

)

Property and equipment, net

 

$

1,228,063

 

 

$

1,280,729

 


Software consisted of the following at January 31, 2015 and April 30, 2014:


 

 

January 31,

 

 

April 30,

 

 

 

2015

 

 

2014

 

Software

 

$

2,147,783

 

 

$

1,894,215

 

Accumulated amortization

 

 

(1,021,466

)

 

 

(720,823

)

Software, net

 

$

1,126,317

 

 

$

1,173,392

 


Amortization expense for all Property and Equipment as well as the portion for just software is presented for the three and nine months ended January 31, 2015 and 2014:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

January 31,

 

 

Nine Months Ended

January 31,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization Expense

 

 

114,559

 

 

 

96,879

 

 

 

329,799

 

 

 

267,762

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Software Amortization Expense

 

 

104,441

 

 

 

87,610

 

 

 

300,642

 

 

 

242,259

 


The following is a schedule of estimated future amortization expense of software at January 31, 2015:


Year Ending April 30,

 

 

 

2015

 

$

107,389

 

2016

 

 

428,711

 

2017

 

 

305,979

 

2018

 

 

172,944

 

2019

 

 

111,294

 

Total

 

$

1,126,317

 



12



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



Note 5. Courseware


Courseware costs capitalized were $109,305 for the nine months ended January 31, 2015.


Courseware consisted of the following at January 31, 2015 and April 30, 2014:


 

 

January 31,

 

 

April 30,

 

 

 

2015

 

 

2014

 

Courseware

 

$

2,213,343

 

 

$

2,104,038

 

Accumulated amortization

 

 

(2,055,063

)

 

 

(1,995,156

)

Courseware, net

 

$

158,280

 

 

$

108,882

 


Amortization expense of courseware for the three months and nine months ended January 31, 2015 and 2014:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

January 31,

 

 

Nine Months Ended

January 31,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization Expense

 

 

19,407

 

 

 

25,025

 

 

 

59,907

 

 

 

83,227

 


The following is a schedule of estimated future amortization expense of courseware at January 31, 2015:


Year Ending April 30,

 

 

 

2015

 

$

18,464

 

2016

 

 

50,891

 

2017

 

 

32,257

 

2018

 

 

24,168

 

2019

 

 

32,500

 

Total

 

$

158,280

 


Note 6. Loan Payable Officer – Related Party


On June 28, 2013, the Company received $1,000,000 as a loan from the Chief Executive Officer. This loan was for a term of 6 months with an annual interest rate of 10%, payable monthly. On September 25, 2013, as a term of the convertible debenture issued as discussed in Note 7, the maturity of the debt to the CEO has been extended to April 2, 2015. On July 16, 2014, the maturity of the debt to the CEO was extended to January 1, 2016. Subsequently, in March 2015, the debt was extended to July 31, 2016.


Note 7. Convertible Notes, Convertible Notes – Related Party and Debenture Payable


On February 25, 2012, February 27, 2012 and February 29, 2012, loans payable of $100,000, $50,000 and $50,000, respectively, were converted into two-year convertible promissory notes, bearing interest of 0.19% per annum. Beginning March 31, 2012, the notes were convertible into common shares of the Company at the rate of $1.00 per share. The Company evaluated the convertible notes and determined that, for the embedded conversion option, there was no beneficial conversion value to record as the conversion price is considered to be the fair market value of the common shares on the note issue dates. These loans (now convertible promissory notes) were originally due in February 2014, and were included in current liabilities as of October 31, 2014 and April 30, 2014. Two of the above mentioned notes were modified in February 2014, see below, and the third became due in February 2014. The amount due under this note has been reserved for payment upon the note being tendered to the Company by the note holder.




13



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



On February 18, 2014 the Company renegotiated the terms of one of the $50,000 convertible notes, specifically the one dated February 27, 2012. The maturity date was extended to December 1, 2014 and the conversion price has been reduced to $0.19 per share. The interest rate has been amended to 3.25% from February 27, 2012. This was treated as a note extinguishment in accordance with ASC 470-50. No gain or loss on extinguishment was recorded and no beneficial conversion feature existed on the modification date. This note was converted to common shares on December 1, 2014. (See Note 9)


On February 28, 2014 the Company renegotiated the terms of the $100,000 convertible note dated February 25, 2012. A payment was made in the amount of $25,000 on February 28, 2014, reducing the principal to $75,000. Another principal payment of $25,000 was made on August 1, 2014 and $50,000 will be made on December 1, 2014. The interest rate was raised to 3.25% from February 25, 2012. The conversion price was reduced to $0.19 per share. This was treated as a note extinguishment in accordance with ASC 470-50. No gain or loss on extinguishment was recorded and no beneficial conversion feature existed on the modification date. The remaining $50,000 balance of this note was converted to common shares on December 1, 2014. (See Note 9)


On March 13, 2012, the Company’s CEO loaned the Company $300,000 and received a convertible promissory note due March 31, 2013, bearing interest at 0.19% per annum. The note is convertible into common shares of the Company at the rate of $1.00 per share upon five days written notice to the Company. The Company evaluated the convertible note and determined that, for the embedded conversion option, there was no beneficial conversion value to record as the conversion price is considered to be the fair market value of the common shares on the note issue date. On September 4, 2012, the maturity date was extended to August 31, 2013. On July 16, 2014, the maturity of the debt to the CEO has been extended to January 1, 2016 and on March 4, 2015, the debt was extended to July 31, 2016. There was no accounting effect for these modifications.


On August 14, 2012, the Company’s CEO loaned the Company $300,000 and received a convertible promissory note, payable on demand, bearing interest at 5% per annum. The note is convertible into shares of common stock of the Company at a rate of $0.35 per share (based on proceeds received on September 28, 2012 under a private placement at $0.35 per unit). The Company evaluated the convertible notes and determined that, for the embedded conversion option, there was no beneficial conversion value to record as the conversion price is considered to be the fair market value of the shares of common stock on the note issue date. On September 4, 2012, the maturity date was extended to August 31, 2013. On December 17, 2012 the maturity date was extended to August 31, 2013. On September 25, 2013, as a term of the convertible Debenture issued as discussed further in this Note, the maturity of the debt to the CEO has been extended to April 5, 2015. On July 16, 2014, the maturity of the debt to the CEO has been extended to January 1, 2016 and on March 4, 2015, the debt was extended to July 31, 2016. There was no accounting effect for these modifications.




14



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



On September 26, 2013, the Company and an institutional investor (the "Institutional Investor") signed a Securities Purchase Agreement (the “Agreement”) with respect to a loan of $2,240,000 evidenced by an 18 month original issue discount secured convertible debenture (the "Debenture") with gross proceeds of $2,000,000 prior to fees. Payments on the Debenture were due 25% on November 1, 2014, 25% on January 1, 2015 and the remaining 50% on April 1, 2015 as a final payment. The Company had the option to pay the interest or principal in stock subject to certain “Equity Conditions” such as giving notice of its intent 20 trading days beforehand. The Agreement provided that the Debenture may have been converted at the holder’s option at $0.3325 per share at any time after the closing and subject to adjustments. The Company evaluated that for the embedded conversion option, there was no beneficial conversion value to record as the conversion price was greater than the fair market value of the common shares on the note issue date. Warrants with a relative fair value of $389,565 were issued for 100% of the number of shares of common stock that could be purchased at the conversion price at closing or 6,736,842. The warrants have a five-year term and are exercisable for cash if an outstanding registration statement is in effect within 90 days of closing. The $389,565 was recorded as a debt discount to be amortized over the debt term. The Debenture bore 8% per annum interest and was amortizable in installments over its term. The financing closed on September 26, 2013 and the Company received proceeds of approximately $1.7 million, net of certain offering costs and before payment of various debt issue costs. Offering costs to the lender included an original issue discount of $240,000 and cash loan fees of $117,846. At July 31, 2014, the balance of the Debenture payable was $1,911,572, which was the loan of $2,240,000 less $328,428 of unamortized original issue discount. On September 4, 2014, Aspen used part of the equity offering proceeds to fully prepay principal and interest owed under its outstanding debenture held by Institutional Investor. Aspen paid them $2,310,000, after entering into an agreement whereby the Institutional Investor agreed to the prepayment and agreed to limit the future sale of shares of common stock upon exercise of its warrants or otherwise. Of the $2,310,000 payment, $70,000 was for interest. Upon repayment of the debenture, the $70,000 interest payment, along with the balance of the debt discount and the debt issuance costs totaling $452,503, was expensed in the Loss from debt extinguishment line on the Statement of Operations.


In September 2013 Company had entered into an engagement agreement with Laidlaw & Co. ("Laidlaw") to act as placement agent for the offering and receive customary compensation. Laidlaw introduced the Institutional Investor. As a placement agent fee, the Company paid Laidlaw $207,500 and issued 1,347,368 five year warrants with an exercise price of $0.3325, valued at $94,316. The warrants and fees paid plus legal fees of $35,356 were recorded as a debt issue cost asset and were being amortized over the debt term. The discount was expensed to interest expense upon repayment of the debenture.


Note 8. Commitments and Contingencies


Line of Credit


The Company maintains a line of credit with a bank, up to a maximum credit line of $250,000. The line of credit bears interest equal to the prime rate plus 0.50% (overall interest rate of 3.75% at January 31, 2015). The line of credit requires minimum monthly payments consisting of interest only. The line of credit is secured by all business assets, inventory, equipment, accounts, general intangibles, chattel paper, documents, instruments and letter of credit rights of the Company. The line of credit is for an unspecified time until the bank notifies the Company of the Final Availability Date, at which time payments on the line of credit become the sum of: (a) accrued interest and (b) 1/60th of the unpaid principal balance immediately following the Final Availability Date, which equates to a five-year payment period. The balance due on the line of credit as of January 31, 2015 was $243,989. Since the earliest the line of credit is due and payable is over a five year period and the Company believes that it could obtain a comparable replacement line of credit elsewhere, the entire line of credit is included in long-term liabilities. The unused amount under the line of credit available to the Company at January 31, 2015 was $6,011.


Employment Agreements


From time to time, the Company enters into employment agreements with certain of its employees. These agreements typically include bonuses, some of which are performance-based in nature. As of January 31, 2015, no performance bonuses have been earned.




15



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



Legal Matters


From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of January 31, 2015, except as discussed below, there were no other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.


On February 11, 2013, HEMG and Mr. Spada sued the Company, certain senior management members and our directors in state court in New York seeking damages arising principally from (i) allegedly false and misleading statements in the filings with the SEC and the DOE where the Company disclosed that HEMG and Mr. Spada borrowed $2.2 million without board authority, (ii) the alleged breach of an April 2012 agreement whereby the Company had agreed, subject to numerous conditions and time limitations, to purchase certain shares of the Company from HEMG, and (iii) alleged diminution to the value of HEMG’s shares of the Company due to Mr. Spada’s disagreement with certain business transactions the Company engaged in, all with Board approval. On November 8, 2013, the state court in New York granted the Company’s motion to dismiss all of the derivative claims and all of the fiduciary duty claims. The state court in New York also granted the Company’s motion to dismiss the duplicative breach of good faith and fair dealing claim, as well as the defamation claim. The state court in New York denied the Company’s motion to dismiss as to the defamation per se claim. On December 10, 2013, the Company filed a series of counterclaims against HEMG and Mr. Spada in state court of New York. Discovery is currently being pursued by the parties. By decision and order dated August 4, 2014, the New York court denied HEMG and Spada’s motion to dismiss the fraud counterclaim the Company asserted against them. The New York court dismissed the Company’s related “money had and received”, “money lent” and “unjust enrichment” claims as being duplicative of the fraud claim.  HEMG and Spada have filed a notice of appeal of the New York court’s decision to the extent it denied the non-fraud claims as being duplicative.


On November 21, 2013, HEMG and Mr. Spada filed a derivative suit on behalf of the Company against certain former senior management member and our directors in state court in Delaware. The Company is a nominal defendant. The complaint is substantially similar to the complaint filed in state court of New York, except that if successful, the Company will receive the benefits. On February 28, 2014, the Company filed a motion to dismiss the complaint. On November 3, 2014, the Chancery Court of the State of Delaware dismissed the shareholders’ derivative lawsuit of Mr. Patrick Spada and Higher Education Management Group, Inc. against ˿Ƶ., certain members of the Company’s Board of Directors and former Chief Financial Officer (collectively, the “Defendants”).  The Court granted the Defendant’s Motion to Dismiss in its entirety and therefore the Delaware case has been dismissed with prejudice and those claims are finally disposed of.  


While the Company has been advised by its counsel that the New York lawsuit is baseless, the Company cannot provide any assurance as to the ultimate outcome of the case. Defending the lawsuit will be expensive and will require the expenditure of time which could otherwise be spent on the Company’s business. While unlikely, if Mr. Spada’s and HEMG’s claims in the New York litigation were to be successful, the damages the Company could pay could potentially be material.


Finally, HEMG has failed to pay to the Company any portion of the $772,793 amount overdue as of September 30, 2014 (as discussed in Note 3), despite due demand for same. Consequently, on November 18, 2014 the Company filed a complaint vs. HEMG in the United States District Court for the District of New Jersey, to collect the full amount due to the Company and intends to sell the 654,850 pledged shares to reduce, in part, this overdue sum. See Note 3.  HEMG failed to answer the complaint and as a result the Court entered a default against HEMG.  We are awaiting the entry of a money judgment against HEMG.




16



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



Regulatory Matters


The Company’s subsidiary, Aspen University, is subject to extensive regulation by Federal and State governmental agencies and accrediting bodies. In particular, the Higher Education Act (the “HEA”) and the regulations promulgated thereunder by the DOE subject Aspen University to significant regulatory scrutiny on the basis of numerous standards that schools must satisfy to participate in the various types of federal student financial assistance programs authorized under Title IV of the HEA. Aspen University has had provisional certification to participate in the Title IV programs. That provisional certification imposes certain regulatory restrictions including, but not limited to, a limit of 1,200 student recipients for Title IV funding for the duration of the provisional certification. The provisional certification restrictions continue with regard to Aspen University’s participation in Title IV programs.


To participate in the Title IV programs, an institution must be authorized to offer its programs of instruction by the relevant agencies of the State in which it is located, and since July 2011, potentially in the States where an institution offers postsecondary education through distance education. In addition, an institution must be accredited by an accrediting agency recognized by the DOE and certified as eligible by the DOE. The DOE will certify an institution to participate in the Title IV programs only after the institution has demonstrated compliance with the HEA and the DOE’s extensive academic, administrative, and financial regulations regarding institutional eligibility and certification. An institution must also demonstrate its compliance with these requirements to the DOE on an ongoing basis. Aspen University performs periodic reviews of its compliance with the various applicable regulatory requirements. As Title IV funds received in fiscal 2014 represented approximately 33% of the Company's cash revenues (including revenues from discontinued operations), as calculated in accordance with Department of Education guidelines, the loss of Title IV funding would have a material effect on the Company's future financial performance.


On March 27, 2012 and on August 31, 2012, Aspen University provided the DOE with letters of credit for which the due date was extended to December 31, 2013. On January 30, 2014, the DOE provided Aspen University with an option to become permanently certified by increasing the letter of credit to 50% of all Title IV funds received in the last program year, equaling $1,696,445, or to remain provisionally certified by increasing the 25% letter of credit to $848,225. Aspen informed the DOE of its desire to remain provisionally certified and posted the $848,225 letter of credit for the DOE on April 14, 2014. On February 26, 2015, Aspen University was informed by the DOE that it again has the option to become permanently certified by increasing the letter of credit to 50% of all Title IV funds received in the last program year, equaling $2,244,971, or to remain provisionally certified by increasing the existing 25% letter of credit to $1,122,485. Aspen informed the DOE on March 3, 2015 of its desire to remain provisionally certified and post the $1,122,485 letter of credit for the DOE by April 30, 2015. The DOE may impose additional or different terms and conditions in any final provisional program participation agreement that it may issue (See Note 2 “Restricted Cash”).


The HEA requires accrediting agencies to review many aspects of an institution's operations in order to ensure that the education offered is of sufficiently high quality to achieve satisfactory outcomes and that the institution is complying with accrediting standards. Failure to demonstrate compliance with accrediting standards may result in the imposition of probation, the requirements to provide periodic reports, the loss of accreditation or other penalties if deficiencies are not remediated.


Because Aspen University operates in a highly regulated industry, it may be subject from time to time to audits, investigations, claims of noncompliance or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions or common law causes of action.




17



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



Return of Title IV Funds


An institution participating in Title IV programs must correctly calculate the amount of unearned Title IV program funds that have been disbursed to students who withdraw from their educational programs before completion and must return those unearned funds in a timely manner, no later than 45 days of the date the school determines that the student has withdrawn. Under Department regulations, failure to make timely returns of Title IV program funds for 5% or more of students sampled on the institution's annual compliance audit in either of its two most recently completed fiscal years can result in the institution having to post a letter of credit in an amount equal to 25% of its required Title IV returns during its most recently completed fiscal year. If unearned funds are not properly calculated and returned in a timely manner, an institution is also subject to monetary liabilities or an action to impose a fine or to limit, suspend or terminate its participation in Title IV programs.


Subsequent to a program review by the Department of Education, the Company recognized that it had not fully complied with all requirements for calculating and making timely returns of Title IV funds (R2T4). In November 2013, the Company returned a total of $102,810 of Title IV funds to the Department of Education.


Delaware Approval to Confer Degrees


Aspen University is a Delaware corporation. Delaware law requires an institution to obtain approval from the Delaware Department of Education (“Delaware DOE”) before it may incorporate with the power to confer degrees. On July 3, 2012, Aspen University received notice from the Delaware DOE that it is granted provisional approval status effective until June 30, 2015. Aspen University is authorized by the Colorado Commission on Education to operate in Colorado as a degree granting institution.


Letter of Credit


The Company maintains a letter of credit under a DOE requirement (See Note 2 “Restricted Cash”).


Note 9. Stockholders’ Equity (Deficiency)


Common Stock


On June 4, 2014, a member of the Board of Directors invested $50,000 in exchange for 263,158 shares of common stock and 263,158 warrants at $0.19 per share. On June 24, 2014, a member of the Board of Directors and the Company’s CEO each invested $50,000 in exchange for 263,158 shares of common stock and 263,158 warrants at $0.19 per share.


On July 29, 2014, as part of a private placement offering, seven accredited investors, including the Company’s CFO, paid a total of $1,631,500 in exchange for 10,525,809 shares of common stock and 5,262,907 five-year warrants exercisable at $0.19 per share. Aspen incurred $75,000 of expenses relating to this offering. As a result of this private placement, on July 31, 2014, Aspen issued 3,473,259 shares of common stock to prior investors who had price protection on their investments, issued 2,662,139 warrants to a prior investor who had price protection on their investment, and reduced the exercise and conversion price on 14,451,613 outstanding warrants and its outstanding Debenture to $0.155.


On September 4, 2014, Aspen raised $3,766,325 from the sale of 24,298,877 shares of common stock and 12,149,439 five-year warrants exercisable at $0.19 per share in a private placement offering to 15 accredited investors. In connection with the offering, Aspen agreed to register the shares of common stock and the shares of common stock underlying the warrants. The net proceeds to Aspen were approximately $3.7 million. As a result of the private placement, Aspen issued 59,423 shares of common stock to a prior investor who had price protection on his investment.


On December 1, 2014, $100,000 of convertible debt was converted into common stock at the conversion rate of $0.19 per share, equally for two investors. Each investor received 263,158 shares of common stock.


On January 14, 2015, 210,526 shares of stock were issued for services provided to Aspen. The shares were valued at the fair market value of the common stock or $0.155 and accordingly, the Company recorded an expense of $32,632.



18



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)




On September 30, 2014, Aspen Group filed a Certificate of Amendment to its Certification of Incorporation increasing its authorized shares from 120,000,000 shares to 250,000,000 shares.


Warrants


A summary of the Company’s warrant activity during the nine months ended January 31, 2015 is presented below:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

Warrants

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Balance Outstanding, April 30, 2014

 

 

23,144,005

 

 

$

0.31

 

 

 

 

 

 

 

Granted

 

 

20,863,958

 

 

 

0.19

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Outstanding, January 31, 2015

 

 

44,007,963

 

 

$

0.25

 

 

 

4.1

 

 

$

299,903

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, January 31, 2015

 

 

44,007,963

 

 

$

0.25

 

 

 

4.1

 

 

$

299,903

 


On June 4, 2014, a member of the Board of Directors invested $50,000 in exchange for 263,158 shares of common stock and 263,158 warrants at $0.19 per share. On June 24, 2014, a member of the Board of Directors and the Company’s CEO each invested $50,000 in exchange for 263,158 shares of common stock and 263,158 warrants at $0.19 per share.


On July 29, 2014, as part of a private placement offering seven accredited investors, including the Company’s CFO, paid a total of $1,631,500 from the sale of 10,525,809 shares of common stock and 5,262,907 five-year warrants exercisable at $0.19 per share. As a result of this private placement, on July 31, 2014, Aspen issued 3,473,259 shares of common stock to prior investors who had price protection on their investments, issued 2,662,139 warrants to a prior investor who had price protection on their investment and reduced the exercise and conversion price on 14,451,613 outstanding warrants and its outstanding Debenture to $0.155.


On September 4, 2014, as part of a private placement offering fifteen accredited investors paid a total of $3,766,325 from the sale of 24,298,877 shares of common stock and 12,149,439 five-year warrants exercisable at $0.19 per share. As a result of this private placement, on July 31, 2014, Aspen issued 59,423 shares of common stock to a prior investor who had price protection on his investment.


Warrants issued to an investor were modified on January 31, 2015 to reduce the exercise price to $0.19 per share. As a result of the modification, the modification expense was not material.


Certain of the Company’s warrants contain price protection. The Company evaluated whether the price protection provision of the warrant would cause derivative treatment. In its assessment, the Company determined that since its shares are not readily convertible to cash due to an inactive trading market, through January 31, 2015 the warrants are excluded from derivative treatment.


Stock Incentive Plan and Stock Option Grants to Employees and Directors


Immediately following the closing of the Reverse Merger, on March 13, 2012, the Company adopted the 2012 Equity Incentive Plan (the “Plan”) that provides for the grant of 9,300,000 shares, 14,300,000 effective July 2014 and 16,300,000 effective September 2014, in the form of incentive stock options, non-qualified stock options, restricted shares, stock appreciation rights and restricted stock units to employees, consultants, officers and directors. As of January 31, 2015, there were 1,723,588 shares remaining under the Plan for future issuance.




19



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term, expected dividend yield rate over the expected option term, and an estimate of expected forfeiture rates. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.


A summary of the Company’s stock option activity for employees and directors during the nine months ended January 31, 2015 is presented below:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

Options

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Balance Outstanding, April 30, 2014

 

 

10,476,412

 

 

$

0.23

 

 

 

3.5

 

 

 

 

Granted

 

 

3,900,000

 

 

$

0.21

 

 

 

3.4

 

 

$

103,000

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(20,000

)

 

$

0.19

 

 

 

4.1

 

 

$

1,200

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Outstanding, January 31, 2015

 

 

14,356,412

 

 

$

0.21

 

 

 

3.4

 

 

$

103,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, January 31, 2015

 

 

5,710,470

 

 

$

0.26

 

 

 

2.9

 

 

$

4,000

 


On September 4, 2014, 2,600,000 options were granted to the CEO and the Board of Directors. The fair value of these options on the date of grant is $130,000 and the exercise price is $0.155 per option. On September 16, 2014, 200,000 options were granted to two members of the Board of Directors. The fair value of these options on the date of grant is $12,000 and the exercise price is $0.20 per option.


On November 24, 2014, the CFO was granted 300,000 stock options. The fair value of these options is $21,000 and the exercise price was $0.234. On December 11, 2014, each of the 8 non-employee members of the Board of Directors was granted 100,000 stock options. The fair value of the options was $7,000 each and the exercise price was $0.2026.


As of January 31, 2015, there was $644,450 of total unrecognized compensation costs related to nonvested share-based compensation arrangements. That cost is expected to be recognized over a weighted-average period of 4 years.


The Company recorded compensation expense of $123,085 and $334,723 for the three and nine months ended January 31, 2015 in connection with employee stock options. $98,610 and $395,940 was recorded during the same period in 2014.


Stock Option Grants to Non-Employees


There were no stock options granted to non-employees during the nine months ended January 31, 2015. The Company recorded no compensation expense for the three months ended January 31, 2015 and $748 for the nine months ended January 31, 2015 in connection with non-employee stock options. $748 was recorded for the three months ended January 31, 2014, and $1,496 for the six months ended January 31, 2014. There was no unrecognized compensation cost at January 31, 2015.




20



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

January 31, 2015

(Unaudited)



A summary of the Company's stock option activity for non-employees during the nine months ended January 31, 2015 is presented below:


 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

Options

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Balance Outstanding, April 30, 2014

 

 

270,000

 

 

$

0.28

 

 

 

2.8

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(50,000

)

 

$

0.19

 

 

 

3.7

 

 

$

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Outstanding, January 31, 2015

 

 

220,000

 

 

$

0.30

 

 

 

2.3

 

 

$

4,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, January 31, 2015

 

 

73,333

 

 

$

0.30

 

 

 

2.3

 

 

$

1,500

 

  

Note 10. Related Party Transactions


See Note 3 for discussion of secured note and account receivable to related parties and see Notes 6 and 7 for discussion of loans payable and convertible notes payable to related parties.


Note 11. Subsequent Events


On February 25, 2015, the DEAC informed Aspen University that it had renewed its accreditation for five years to January, 2019.


On February 26, 2015, Aspen University was informed by the DOE that it has the option to become permanently certified by increasing the letter of credit to 50% of all Title IV funds received in the last program year, equaling $2,244,971, or to remain provisionally certified by increasing the existing 25% letter of credit to $1,122,485. Aspen informed the DOE on March 3, 2015 of its desire to remain provisionally certified and post the $1,122,485 letter of credit for the DOE by April 30, 2015.


On or about February 20, 2015, ˿Ƶ. filed a motion in the United States District Court, District of New Jersey, seeking the entry of a money  judgment on default against Defendant, HEMG, in the amount of $772,793, plus interest, costs, disbursements, and any other relief the Court deems just and proper. (See Note 3)


On March 4, 2015, Mr. Michael Mathews, for no consideration, extended the due date of his loans from January 1, 2016 to July 31, 2016.





21





ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion in conjunction with our unaudited consolidated financial statements, which are included elsewhere in this Form 10-Q. Management’s Discussion and Analysis of Financial Condition and Results of Operations contain forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed in the Risk Factors contained in the Annual Report on Form 10-K filed July 29, 2014, filed with the Securities and Exchange Commission, or the SEC.


All references to “we,” “our” and “us” refer to ˿Ƶ. and its subsidiaries (including Aspen), unless the context otherwise indicates. In referring to academic matters, these words refer solely to Aspen University.


Company Overview


Founded in 1987, Aspen’s mission is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education for the purpose of achieving sustainable economic and social benefits for themselves and their families. Because we believe higher education should be a catalyst to our students’ long-term economic success, we exert financial prudence by offering affordable tuition that is one of the greatest values in online higher education.


On March 20, 2014, Aspen University unveiled a monthly payment plan aimed at reversing the college-debt sentence plaguing working-class Americans. The monthly payment plan offers bachelor students the opportunity to pay $250/month for 60 months ($15,000) and master/doctoral students the opportunity to pay $325/month for 36 months ($11,700), thereby giving students the ability to earn a degree debt free. In the eleven months since the announcement, already 33% of courses are now paid through monthly payment methods.


One of the key differences between Aspen and other publicly-traded, exclusively online, for-profit universities is that approximately 38% of our full-time degree-seeking students (as of January 31, 2015) were enrolled in Aspen’s School of Nursing.


On November 10, 2014, Aspen University announced the Commission on Collegiate Nursing Education (“CCNE”) has granted accreditation to its Bachelor of Science in Nursing program (RN to BSN) until December 31, 2019. This newly accredited undergraduate degree program is expected to grow rapidly given Aspen’s debtless education approach, which allows nurses to pay the $9,750 tuition for the 10-course RN to BSN completion program at $250 per month for 39 months. In fact, Aspen projects the BSN program to be the largest growth driver in the next 12 months, which we estimate will result in over 50% or the majority of the degree-seeking student body to be enrolled in the School of Nursing by early-2016.


Since 1993, we have been nationally accredited by the Distance Education and Accrediting Council (“DEAC”), a national accrediting agency recognized by the U.S. Department of Education (the “DOE”).  On February 25, 2015, the DEAC informed Aspen University that it had renewed its accreditation for five years to January, 2019.


Student Population


Aspen’s full-time degree-seeking student body increased year-over-year by 27% during the quarter ended January 31, 2015, from 2,373 to 3,011 students. In addition, 1,132 students are enrolled in part-time programs, such as continuing education courses and certificate level programs.


Our most popular school is our School of Nursing. Aspen’s School of Nursing has grown from 5% of our full-time, degree-seeking student body at calendar year-end 2011, to 38% of our full-time, degree-seeking student body at January 31, 2015. Aspen’s School of Nursing grew from 733 to 1,151 student’s year-over-year, which represented 66% of Aspen’s full-time degree-seeking student body growth.




22





New Student Enrollment Overview


Since the launch of the BSN marketing campaign in mid-November, 2014, the growth rate of new student enrollments has accelerated significantly. Typically, it takes 60-90 days for a new student lead to convert into an enrollment.  However, Aspen began seeing BSN leads convert to new student enrollments at the beginning of January, only six weeks following the marketing campaign launch. As previously announced, Aspen is forecasting new student enrollments to increase 81% year-over-year in the current quarter ending April 30, 2015.


Aspen has updated its definition of a new student enrollment to only report those new students that complete their first seven (7) day assignment of their first course in their degree program. Based on that definition, below is a quarterly analysis of new student enrollments for the previous four quarters, including Aspen’s forecast for the current quarter ending April 30, 2015.


New Student Enrollments


Fiscal Quarter End April 30, 2014

 

235

 

 

 

Fiscal Quarter End July 31, 2014

 

226

 

 

 

Fiscal Quarter End October 31, 2014

 

265

 

 

 

Fiscal Quarter End January 31, 2015

 

315

 

 

 

Fiscal Quarter End April 30, 2015

 

425+

(forecast)

 

 



In the month of February 2015, typically a seasonally slow month for new student enrollments, Aspen enrolled 141 new students which equals an average of 5.04 enrollments per day.


Aspen’s estimated average revenue per new student enrollment is approximately $6,000, earned over 3 years. Aspen delivered 1,008 new student enrollments in calendar year 2014, which equates to revenues of approximately $6 million, earned over three years. However, should the pace of enrollments continue to rise by 81% year-over-year in calendar year 2015, that would equate to 1,704 new student enrollments with a revenue value of approximately $10.2 million, earned over three years.


Results of Operations


For the Three Months Ended January 31, 2015 Compared with the Three Months Ended January 31, 2014

 

Revenue


Revenue from continuing operations for the three months ended January 31, 2015 (“2015 Quarter”) increased to $1,286,138 from $1,002,167 for the three months ended January 31, 2014 (“2014 Quarter”), an increase of 28%. The increase is primarily attributable to the growth in Aspen’s School of Nursing student enrollments and Nursing student class starts. Specifically, revenues from Aspen’s School of Nursing increased to $541,865 during the 2015 Quarter from $388,650 during the 2014 Quarter, an increase of 39%.




23





Cost of Revenues (exclusive of amortization)


The Company’s cost of revenues consist of instructional costs and services and marketing and promotional costs.


Instructional Costs and Services


Instructional costs and services for the 2015 Quarter rose to $298,149 from $229,907 for the 2014 Quarter, an increase of $68,242 or 30%. As student enrollment levels increase, instructional costs and services should rise proportionately. However, as Aspen increases its full-time degree-seeking student enrollments and related class starts, the higher gross margins associated with such students should lead to the growth rate in instructional costs and services to significantly lag that of overall revenue growth.


Marketing and Promotional

 

Marketing and promotional costs for the 2015 Quarter were $364,219 compared to $270,404 for the 2014 Quarter, an increase of $93,816 or 35%. This increase reflects an increased monthly marketing budget to $110,000, starting in December, 2014. The planned spending increase was previously announced following the CCNE accreditation announcement of Aspen’s BSN program in November, 2014.


As a result of the planned marketing spending increase in the 2015 quarter, Gross Profit was flat at 39% of revenues or $499,922 for the 2015 Quarter compared to 39% of revenues or $389,221 for the 2014 Quarter. Gross Profit (exclusive of amortization), a non-GAAP financial measure, declined slightly to 49% of revenues or $623,770 for the 2015 Quarter from 50% of revenues or $501,856 for the 2014 Quarter, a year-over-year decrease of 2%.  The increase of Gross Profit (exclusive of amortization) from $501,856 to $623,770 is an increase of $121,914 or 24% year-over-year.


Costs and Expenses


General and Administrative


General and administrative costs for the 2015 Quarter were $1,701,871 compared to $1,752,717 during the 2014 Quarter, a decrease of $50,846 or 3%. The decrease is attributable primarily to the lower Bad Debt Expense, which was $12,228 in 2015 Quarter compared to $105,000 in the 2014 Quarter. Also, there were decreases in consulting expenses from 2014 Quarter, expenses resulting from the DOE Program Review.  These decreases were completely offset by expenses in the 2015 Quarter relating to the consulting agreements with two former executives.


Receivable Collateral Valuation Reserve


In 2014 Quarter, a reserve of $123,647 was taken to reflect the reduction in the price of the Company’s stock.  There was no comparable reserve for 2015 Quarter.


Depreciation and Amortization


Depreciation and amortization costs for the 2015 Quarter rose to $133,966 from $121,904 for the 2014 Quarter, an increase of $12,062 or 10%. The increase is primarily attributable to higher levels of capitalized technology costs as Aspen launched a new academic learning system, Desire2Learn.


Other Income (Expense)


Other income for the 2015 Quarter increased to $2,277 from $136 in the 2014 Quarter, an increase of $2,141 or 1,574%. The increase is primarily due to the sale of excess textbooks. Interest expense decreased from $260,602 to $34,532, a decrease of $225,530 or 87%. The decrease is due to the elimination of the monthly interest to the Institutional Investor along with the amortization of the debt discount and the debt issuance costs.




24





Income Taxes

 

Income taxes expense (benefit) for the 2015 Quarter and 2014 Quarter was $0 as Aspen Group experienced operating losses in both periods. As management made a full valuation allowance against the deferred tax assets stemming from these losses, there was no tax benefit recorded in the statement of operations in both periods.


Net Loss

 

Net loss for the 2015 Quarter was ($1,244,322) as compared to ($1,726,587) for the 2014 Quarter, a decrease in the loss of $482,265 or approximately 28%.  Contributing to this lower loss was the increase in revenues in the 2015 Quarter, as well as lower interest expense in the 2015 Quarter and no receivable collateral valuation reserve in the 2015 Quarter.


For the Nine Months Ended January 31, 2015 Compared with the Nine Months Ended January 31, 2014

 

Revenue


Revenue from continuing operations for the nine months ended January 31, 2015 (“2015 Period”) increased to $3,670,245 from $2,817,497 for the nine months ended January 31, 2014 (“2014 Period”), an increase of $852,748 or 30%. Of particular note, revenues from Aspen’s Nursing degree program increased to $1,419,990 during the 2015 Period from $1,002,372 during the 2014 Period, an increase of $417,618 or 42%.

 

Cost of Revenues (exclusive of amortization)


The Company’s cost of revenues consist of instructional costs and services and marketing and promotional costs.


Instructional Costs and Services


Instructional costs and services for the 2015 Period rose to $816,681 from $566,442 for the 2014 Period, an increase of $250,239 or 44%. As student enrollment levels increase, instructional costs and services should rise proportionately. However, as Aspen increases its full-time degree-seeking student enrollments and related class starts, the higher gross margins associated with such students should lead to the growth rate in instructional costs and services to significantly lag that of overall revenue growth.


Marketing and Promotional

 

Marketing and promotional costs for the 2015 Period were $708,112 compared to $824,002 for the 2014 Period, a decrease of $115,890 or 14%. This decrease reflects significant marketing efficiencies gained year-over-year. The company expects marketing and promotional costs to rise in future periods given the planned spend rate increase to an average of $110,000 per month which began in December 2014.


Gross Profit rose to 49% of revenues or $1,784,903 for the 2015 Period from 39% of revenues or $1,101,567 for the 2014 Period. Gross Profit (exclusive of amortization), a non-GAAP financial measure, rose to 58% of revenues or $2,145,452 for the 2015 Period from 51% of revenues or $1,427,053 for the 2014 Period, a year-over-year increase of $718,399 or 50%.




25





Costs and Expenses


General and Administrative


General and administrative costs for the 2015 Period were $4,160,978 compared to $4,866,498 during the 2014 Period, a decrease of $705,520 or 15%. The decrease is attributable to the elimination of expenses year-over-year primarily due to a $400,000 decrease in professional services, including $170,000 due to the DOE program review, a reduction in $300,000 in investor relations and $40,000 due to the audit related to the change in our fiscal year to April 30.  There was also a $100,000 reduction in payroll expense, a $92,000 reduction in a marketing consulting, a $30,000 decrease of expenses related to the biennial graduation ceremony. Additionally, stock compensation was $91,000 higher in the 2014 Period relating to the issuance of executive options and there was a $157,000 warrant modification expense in the 2014 Period.


Depreciation and Amortization


Depreciation and amortization costs for the 2015 Period rose to $389,706 from $350,990 for the 2014 Period, an increase of $38,716 or 11%. The increase is primarily attributable to higher levels of capitalized technology costs as Aspen launched a new academic learning system, Desire2Learn, in the 2015 Period.


Other Income (Expense)


Other income for the 2015 Period increased to $7,157 from $750 in the 2014 Period, an increase of $6,407 or 854%. A significant portion of this increase is due to the sale of excess textbooks.  Interest expense decreased from $398,916 to $389,153, a decrease of $9,763 or 2%. Interest was higher each monthly year over year until the extinguishment in September 2014.  Before the extinguishment, the monthly increase year over year was due to the monthly interest expense of $13,333, the amortization of the original issue discount and the amortization of debt issuance costs, all associated with the issuance of debentures. In addition, there is the monthly interest expense of $8,333 on the loan from our CEO.


Loss from Debt Extinguishment


In the 2015 Period, there is a $452,503 loss from the extinguishment of the debenture.  Included in this loss is the final interest payment of $70,000, offset by an interest accrual of $34,084, along with the writeoff of $130,057 of remaining debt issuance costs and $286,530 of remaining original issue discount.


Income Taxes

 

Income taxes expense (benefit) for both nine month periods was $0 as Aspen Group experienced operating losses in both periods. As management made a full valuation allowance against the deferred tax assets stemming from these losses, there was no tax benefit recorded in the statement of operations in both periods.


Net Loss

 

Net loss for 2015 Period was ($3,239,731) as compared to ($4,227,585) for the 2014 Period, a decrease in the loss of $987,854 or approximately 23%. Contributing to this lower loss was the increase in revenues in the 2015 period, lower marketing costs, lower payroll and lower consulting expenses.  




26





Discontinued Operations


As of August 4, 2013, Aspen Group discontinued business activities related to its agreement with CLS. See Note 1 of the unaudited consolidated financial statements contained herein. The following table details the results of the discontinued operations for the three and nine months ended January 31, 2015 and 2014:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

January 31,

 

 

Nine Months Ended

January 31,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

 

 

$

 

 

$

 

 

$

549,125

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Instructional costs and services

 

 

 

 

 

 

 

 

 

 

 

494,213

 

General and administrative

 

 

 

 

 

(29,751

)

 

 

 

 

 

(29,751

)

Total costs and expenses

 

 

 

 

 

(29,751

)

 

 

 

 

 

464,462

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from discontinued operations, net of income taxes

 

$

 

 

$

29,751

 

 

$

 

 

$

84,663

 


Non-GAAP – Financial Measures


The following discussion and analysis includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of Aspen Group nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.


Our management uses and relies on Adjusted EBITDA and Gross Profit (exclusive of depreciation and amortization), which are non-GAAP financial measures. We believe that both management and shareholders benefit from referring to the following non-GAAP financial measures in planning, forecasting and analyzing future periods. Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparison. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the described excluded items.


Aspen Group defines Adjusted EBITDA as earnings (or loss) from continuing operations before the items in the table below. Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period-to-period after removing the impact of items of a non-operational nature that affect comparability.


We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measure calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between Aspen Group and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each company under applicable SEC rules.




27





The following table presents a reconciliation of Adjusted EBITDA to Net loss allocable to common shareholders, a GAAP financial measure:


 

 

 

 

 

Three Months Ended

 

 

 

 

 

 

01/31/2015

 

 

01/31/2014

 

Net loss allocable to common shareholders

 

 

 

 

 

$

(1,244,322

)

 

$

(1,726,587

)

Interest Expense, net of interest income

 

 

 

 

 

 

(34,532

)

 

 

78,854

 

Loss from debt extinguishment

 

 

 

 

 

 

 

 

 

 

Bad Debt Expense

 

 

 

 

 

 

12,228

 

 

 

120,000

 

Receivable Collateral Valuation Reserve

 

 

 

 

 

 

 

 

 

123,664

 

Depreciation & Amortization

 

 

 

 

 

 

133,966

 

 

 

121,904

 

Amortization of Prepaid Services

 

 

 

 

 

 

 

 

 

105,013

 

Amortization of Debt Issue Costs

 

 

 

 

 

 

 

 

 

56,865

 

Amortization of Debt Discount

 

 

 

 

 

 

 

 

 

124,343

 

Warrant conversion exercise expense

 

 

 

 

 

 

 

 

 

156,952

 

Stock-based compensation

 

 

 

 

 

 

123,085

 

 

 

98,609

 

Non-recurring charges

 

 

 

 

 

 

339,522

 

 

 

133,001

 

Adjusted EBITDA (Loss)

 

 

 

 

 

$

(600,522

)

 

$

(607,382

)


The following table presents a reconciliation of Gross Profit (exclusive of amortization), a non-GAAP financial measure, to gross profit calculated in accordance with GAAP:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

January 31,

 

 

January 31,

 

 

 

2015

 

 

2014

 

 

2015

 

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

1,286,138

 

 

$

1,002,167

 

 

$

3,670,245

 

 

$

2,817,497

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of revenues (exclusive of depreciation and amortization shown separately)

 

 

662,368

 

 

 

500,311

 

 

 

1,524,793

 

 

 

1,390,444

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit (exclusive of depreciation and amortization)

 

 

623,770

 

 

 

501,856

 

 

 

2,145,452

 

 

 

1,427,053

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expenses excluded from cost of revenues

 

 

123,848

 

 

 

112,635

 

 

 

360,549

 

 

 

325,486

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP gross profit

 

$

499,922

 

 

$

389,221

 

 

$

1,784,903

 

 

$

1,101,567

 


Liquidity and Capital Resources


A summary of our cash flows is as follows:


 

 

For the

Nine Months Ended

 

 

 

January 31,

 

 

 

2015

 

 

2014

 

 

  

                     

  

  

                     

  

Net cash used in operating activities

 

$

(1,863,341

)

 

$

(3,040,798

)

Net cash used in investing activities

 

 

(406,365

)

 

 

(303,045

)

Net cash provided by financing activities

 

 

3,175,415

 

 

 

3,389,282

 

Net cash provided by discontinued operations

 

 

5,250

 

 

 

80,206

 

Net increase (decrease) in cash and cash equivalents

 

$

910,959

 

 

$

125,645

 




28





Net Cash Used in Operating Activities


Net cash used in operating activities during the 2015 Period totaled ($1,863,341) and resulted primarily from a net loss from continuing operations of ($3,239,731) offset by non-cash items of $1,341,390, comprised of $416,587 from the non-cash portion of the loss on extinguishment of debt, $166,241 of amortization of debt discount, $389,706 in depreciation and amortization, $75,458 of amortization of debt discount, $334,723 of stock compensation expense and $117,739 of bad debt expense, and a net change in operating assets and liabilities of $(210,777), of which the $(356,348) increase in accounts receivable was the most significant.


Net cash used in operating activities during the 2014 Period totaled ($3,040,798) and resulted primarily from a net loss from continuing operations of $(4,227,585) offset by non-cash items of $1,271,450 and a net change in operating assets and liabilities of $(441,409).


Net Cash Used in Investing Activities


Net cash used in investing activities during the 2015 Period totaled ($406,365) and resulted primarily from capitalized technology expenditures.


Net cash used in investing activities during the 2014 Period totaled ($303,045), resulting primarily from capitalized technology expenditures and increase in restricted cash.


Net Cash Provided By Financing Activities


Net cash provided by financing activities during the 2015 Period totaled $3,175,415 which resulted primarily from proceeds from the private placements of $5,547,825, offset by debt repayments of $2,240,000.


Net cash provided by financing activities during the 2014 Period totaled $3,389,282 which resulted primarily from the receipt of a $1,000,000 loan from the CEO and proceeds of $1,639,298 from issuance of convertible debt.


Historical Financings


Historically, our primary source of liquidity is cash receipts from tuition and the issuances of debt and equity securities. The primary uses of cash are payroll related expenses, professional expenses and instructional and marketing expenses.


On July 1, 2013, Mr. Michael Mathews, our Chief Executive Officer, loaned Aspen Group $1 million and was issued a $1 million promissory note. The promissory note bears 10% interest per annum, payable monthly in arrears. Mr. Mathews also holds two $300,000 convertible notes, one of which is convertible at $0.35 per share and the other at $1.00 per share. These Notes held by Mr. Mathews were recently extended to July 31, 2016.

 

In September 2013, the Company sold a $2,240,000 Original Issue Discount Secured Convertible Debenture (the “Debenture”) and 6,736,842 five-year warrants (exercisable at $0.3325) in a private placement offering to an institutional investor. The Company received net proceeds of approximately $1.7 million from this offering.


On January 15, 2014, a warrant exercise offering was completed whereby 4,231,840 warrants were exercised at an exercise price of $0.19 per warrant. The total proceeds received were $804,049 and since the exercise price was discounted from the stated prices of either $0.50 or $0.3325. Related to this, additional 5,178,947 new warrants were issued at $0.19 per warrant as part of a price protection agreement with two investors.


On March 10, 2014, several members of the Board of Directors invested $600,000 in exchange for 3,157,895 shares of common stock and 3,157,895 warrants at $0.19 per share.




29





On July 29, 2014, in the first part of a two part private placement offering, seven accredited investors, including the Company’s CFO, paid a total of $1,631,500 in exchange for 10,525,809 shares of common stock and 5,262,907 five-year warrants exercisable at $0.19 per share. Aspen reimbursed expenses in total of $75,000 related to this offering. As a result of this private placement, on July 31, 2014, Aspen issued 3,473,259 shares of common stock to prior investors who had price protection on their investments, issued 2,662,139 warrants to a prior investor who had price protection on their investment and reduced the exercise and conversion price on 14,451,613 outstanding warrants and its outstanding Debenture to $0.155.


On September 4, 2014, Aspen raised $3,766,325 from the sale of 24,298,877 shares of common stock and 12,149,439 five-year warrants exercisable at $0.19 per share in the second part of a two part private placement offering to 15 accredited investors. The net proceeds to Aspen were approximately $3.7 million. With the proceeds from this offering, we pre-paid the full principal owed and interest due under the Debenture (described above).


Liquidity and Capital Resource Considerations


As of March 10, 2015, the Company had a cash balance of approximately $2.0 million (which includes approximately $870,000 of restricted cash). In September 2014, the Company completed the second closing of its equity financing of $3,766,325. With the additional cash raised in the financing, the growth in the Company revenues and improving operating margins, the Company believes that it has sufficient cash to allow the Company to implement its long-term business plan.


Our cash balances are kept liquid to support our growing infrastructure needs. The majority of our cash is concentrated in large financial institutions.


Critical Accounting Policies and Estimates


In response to financial reporting release FR-60, Cautionary Advice Regarding Disclosure About Critical Accounting Policies, from the SEC, we have selected our more subjective accounting estimation processes for purposes of explaining the methodology used in calculating the estimate, in addition to the inherent uncertainties pertaining to the estimate and the possible effects on the our financial condition. The accounting estimates are discussed below and involve certain assumptions that, if incorrect, could have a material adverse impact on our results of operations and financial condition.


Revenue Recognition and Deferred Revenue


Revenue consisting primarily of tuition and fees derived from courses taught by Aspen online as well as from related educational resources that Aspen provides to its students, such as access to our online materials and learning management system. Tuition revenue is recognized pro-rata over the applicable period of instruction. Aspen maintains an institutional tuition refund policy, which provides for all or a portion of tuition to be refunded if a student withdraws during stated refund periods. Certain states in which students reside impose separate, mandatory refund policies, which override Aspen’s policy to the extent in conflict. If a student withdraws at a time when a portion or none of the tuition is refundable, then in accordance with its revenue recognition policy, Aspen recognizes as revenue the tuition that was not refunded. Since Aspen recognizes revenue pro-rata over the term of the course and because, under its institutional refund policy, the amount subject to refund is never greater than the amount of the revenue that has been deferred, under Aspen’s accounting policies revenue is not recognized with respect to amounts that could potentially be refunded. Aspen’s educational programs have starting and ending dates that differ from its fiscal quarters. Therefore, at the end of each fiscal quarter, a portion of revenue from these programs is not yet earned and is therefore deferred. Aspen also charges students annual fees for library, technology and other services, which are recognized over the related service period. Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets. Other revenue may be recognized as sales occur or services are performed.



30





Accounts Receivable and Allowance for Doubtful Accounts Receivable


All students are required to select both a primary and secondary payment option with respect to amounts due to Aspen for tuition, fees and other expenses. The most common payment option for Aspen’s students is personal funds or payment made on their behalf by an employer. In instances where a student selects financial aid as the primary payment option, he or she often selects personal cash as the secondary option. If a student who has selected financial aid as his or her primary payment option withdraws prior to the end of a course but after the date that Aspen’s institutional refund period has expired, the student will have incurred the obligation to pay the full cost of the course. If the withdrawal occurs before the date at which the student has earned 100% of his or her financial aid, Aspen will have to return all or a portion of the Title IV funds to the DOE and the student will owe Aspen all amounts incurred that are in excess of the amount of financial aid that the student earned and that Aspen is entitled to retain. In this case, Aspen must collect the receivable using the student’s second payment option.


For accounts receivable from students, Aspen records an allowance for doubtful accounts for estimated losses resulting from the inability, failure or refusal of its students to make required payments, which includes the recovery of financial aid funds advanced to a student for amounts in excess of the student’s cost of tuition and related fees. Aspen determines the adequacy of its allowance for doubtful accounts using a general reserve method based on an analysis of its historical bad debt experience, current economic trends, and the aging of the accounts receivable and student status. Aspen applies reserves to its receivables based upon an estimate of the risk presented by the age of the receivables and student status. Aspen writes off accounts receivable balances at the time the balances are deemed uncollectible. Aspen continues to reflect accounts receivable with an offsetting allowance as long as management believes there is a reasonable possibility of collection.


For accounts receivable from primary payors other than students, Aspen estimates its allowance for doubtful accounts by evaluating specific accounts where information indicates the customers may have an inability to meet financial obligations, such as bankruptcy proceedings and receivable amounts outstanding for an extended period beyond contractual terms. In these cases, Aspen uses assumptions and judgment, based on the best available facts and circumstances, to record a specific allowance for those customers against amounts due to reduce the receivable to the amount expected to be collected. These specific allowances are re-evaluated and adjusted as additional information is received. The amounts calculated are analyzed to determine the total amount of the allowance. Aspen may also record a general allowance as necessary.


Direct write-offs are taken in the period when Aspen has exhausted its efforts to collect overdue and unpaid receivables or otherwise evaluate other circumstances that indicate that Aspen should abandon such efforts.


Related Party Transactions


At January 31, 2015, we included as a long term asset an account receivable of $146,831 net of an allowance of $625,962 from HEMG, controlled by Aspen’s former Chairman. Although it is secured by stock pledges, there is a risk that we may not collect all or any of this amount.


HEMG has failed to pay to the Company any portion of the $772,793 amount overdue as of September 30, 2014, despite due demand for same. Consequently, on November 18, 2014 the Company filed a complaint vs. HEMG in the United States District Court for the District of New Jersey, to collect the full amount due to the Company.


See Note 10 to our January 31, 2015 unaudited consolidated financial statements included herein for additional description of related party transactions that had a material effect on our consolidated financial statements.


Off Balance Sheet Arrangements

 

We do not engage in any activities involving variable interest entities or off-balance sheet arrangements.


New Accounting Pronouncements


See Note 2 to our January 31, 2015 unaudited consolidated financial statements included herein for discussion of recent accounting pronouncements.

 



31





Cautionary Note Regarding Forward Looking Statements

 

This report contains forward-looking statements including the expected growth in our undergraduate Nursing degree program, forecasted fourth quarter student enrollments, forecasted revenue from the expected forecasted student enrollments, expected increase or decrease in expenses including an increase in Internet marketing expenses, capital expenditures, and liquidity. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

 

The results anticipated by any or all of these forward-looking statements might not occur. Important factors that could cause actual results to differ from those in the forward-looking statements include the failure to maintain regulatory approvals including our ability to obtain permanent certification from our accreditor, competition, ineffective media and/or marketing, failure to maintain growth in degree seeking students and the failure to generate sufficient revenue. Further information on our risk factors is contained in our filings with the SEC, including the Form 10-K filed on July 29, 2014 and the Prospectus dated October 14, 2014. Any forward-looking statement made by us in this report speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.

  

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.


ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures. Our management carried out an evaluation, with the participation of our Principal Executive Officer and Principal Financial Officer, required by Rule 13a-15 or 15d-15 of the Securities Exchange Act of 1934 (the “Exchange Act”) of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) or 15d-15(e) under the Exchange Act. Based on their evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.




32





PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of January 31, 2015, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest other than described below or previously reported.


On February 11, 2013, HEMG and Mr. Spada sued the Company, certain senior management members and our directors in state court in New York seeking damages arising principally from (i) allegedly false and misleading statements in the filings with the SEC and the DOE where the Company disclosed that HEMG and Mr. Spada borrowed $2.2 million without board authority, (ii) the alleged breach of an April 2012 agreement whereby the Company had agreed, subject to numerous conditions and time limitations, to purchase certain shares of the Company from HEMG, and (iii) alleged diminution to the value of HEMG’s shares of the Company due to Mr. Spada’s disagreement with certain business transactions the Company engaged in, all with Board approval. On November 8, 2013, the state court in New York granted the Company’s motion to dismiss all of the derivative claims and all of the fiduciary duty claims. The state court in New York also granted the Company’s motion to dismiss the duplicative breach of good faith and fair dealing claim, as well as the defamation claim. The state court in New York denied the Company’s motion to dismiss as to the defamation per se claim. On December 10, 2013, the Company filed a series of counterclaims against HEMG and Mr. Spada in state court of New York. Discovery is currently being pursued by the parties. By decision and order dated August 4, 2014, the New York court denied HEMG and Spada’s motion to dismiss the fraud counterclaim the Company asserted against them. The New York court dismissed the Company’s related “money had and received”, “money lent” and “unjust enrichment” claims as being duplicative of the fraud claim. HEMG and Spada have filed a notice of appeal of the New York court’s decision.


As previously reported, HEMG and Mr. Spada filed a derivative suit on behalf of the Company against certain former senior management member and our directors in state court in Delaware. The Company is a nominal defendant. The complaint was substantially similar to the complaint filed in state court of New York.  On November 3, 2014, the Chancery Court of the State of Delaware dismissed the shareholders’ derivative lawsuit of Mr. Patrick Spada and Higher Education Management Group, Inc. against ˿Ƶ., certain members of the Company’s Board of Directors and former Chief Financial Officer (collectively, the “Defendants”). The Court granted the Defendant’s Motion to Dismiss in its entirety.  The Plaintiff’s recently filed a Notice of Appeal.


While the Company has been advised by its counsel that the New York lawsuit is baseless, the Company cannot provide any assurance as to the ultimate outcome of the case. Defending the lawsuit will be expensive and will require the expenditure of time which could otherwise be spent on the Company’s business. While unlikely, if Mr. Spada’s and HEMG’s claims in the New York litigation were to be successful, the damages the Company could pay could potentially be material.


On November 18, 2014, the Company filed a complaint against HEMG in the United States District Court for the District of New Jersey for failure to pay (despite demand) to the Company any portion of the $772,793 amount overdue. The Company is seeking to collect the full amount due.  HEMG failed to answer the complaint and as a result the Court entered a default against HEMG.  We are awaiting the entry of a money judgment against HEMG.


ITEM 1A. RISK FACTORS


Not applicable to smaller reporting companies.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 



33





ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.


ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION


None.


ITEM 6. EXHIBITS

 

See the Exhibit Index at the end of this report.

 

 



34





SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

˿Ƶ.

 

 

 

 

 

March 11, 2015

By:

/s/ Michael Mathews

 

 

 

Michael Mathews

 

 

 

Chief Executive Officer

 

 

 

(Principal Executive Officer)

 

 

 

 

 


March 11, 2015

By:

/s/ Janet Gill

 

 

 

Janet Gill

 

 

 

Chief Financial Officer

 

 

 

(Principal Financial Officer)

 

 

 

 

 

 



35






EXHIBIT INDEX

 

 

 

 

 

 

Incorporated by Reference

 

Filed or Furnished

Exhibit #

 

Exhibit Description

 

 

Form

 

Date

 

 

Number

 

Herewith

3.1

 

Certificate of Amendment to Certificate of Incorporation

 

 

 

 

 

 

 

 

 

Filed

10.1

 

Form of Securities Purchase Agreement

 

 

8-K

 

7/30/14

 

 

10.1

 

 

10.2

 

Form of Registration Rights Agreement

 

 

8-K

 

7/30/14

 

 

10.2

 

 

10.3

 

Form of Warrant

 

 

8-K

 

7/30/14

 

 

10.3

 

 

10.4

 

Form of Convertible Note – Mathews - $1.00

 

 

 

 

 

 

 

 

 

Filed

10.5

 

Form of Convertible Note – Mathews - $0.35

 

 

 

 

 

 

 

 

 

Filed

10.6

 

Promissory Note dated March 4, 2015 - Mathews

 

 

 

 

 

 

 

 

 

Filed

10.7

 

Form of Director Stock Option Agreement

 

 

 

 

 

 

 

 

 

Filed

31.1

 

Certification of Principal Executive Officer (302)

 

 

 

 

 

 

 

 

 

Filed

31.2

 

Certification of Principal Financial Officer (302)

 

 

 

 

 

 

 

 

 

Filed

32.1

 

Certification of Principal Executive and Principal Financial Officer (906)

 

 

 

 

 

 

 

 

 

Furnished**

101.INS

 

XBRL Instance Document

 

 

 

 

 

 

 

 

 

Filed

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

Filed

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

 

 

 

 

 

 

 

 

 

 

 

 

 

———————

*

Represents compensatory plan of management.

**

This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

 










36